Coronavirus Analysis
ICYMI: electroCore's EUA for COVID
The neuromodulation company has leveraged its original R&D into a treatment for COVID-19.
Welcome to MyStrategist, an online experience like no other in the medical device industry.
MedTech Strategist's complimentary Community Blog focuses on the people and the passion behind the global device space. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter Browse
Coronavirus Analysis
Can Rapid Antigen Testing Identify COVID-19 Infectiousness? MTS Panelists Weigh In
Coronavirus Analysis
Deloitte: The Post-COVID-19 Shutdown Rebound: How Medtech Companies Can Help Support Deferred Care and Procedure Recovery
Coronavirus Analysis
Deloitte: Embracing Virtual Health to Help Medtech Companies Thrive
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Perspective & Commentary
In MedTech History: NASDAQ
At the dawn of the 1970s, the Vietnam War was raging, moon landings were becoming more routine, and Walt Disney World opened its doors. It also marks the debut of NASDAQ, which now has a greater trading volume than any other US stock exchange, including many innovative medtech companies.
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.
Subscribe Free Premier Issue Learn More
Investors & Dealmaking
Market Pathways’ Top Articles of 2020
The most-read Market Pathways articles of 2020 reflect a year of non-stop emergency decision-making and creative policymaking.
Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.
Subscribe Now Learn More
Coronavirus Analysis
Market Pathways’ Top Articles of 2020
The most-read Market Pathways articles of 2020 reflect a year of non-stop emergency decision-making and creative policymaking.